4Cyte Pathology
4Cyte Pathology is an Australian independent specialist pathology laboratory founded in 2018 and headquartered in Ryde, NSW, providing diagnostic testing services to the Australian healthcare market via GP and specialist referrals.
- Company typePrivate
- Founded2018
- HeadquartersRyde, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
4Cyte Pathology firmographics
Firmographics- Name
- 4Cyte Pathology
- Website
- https://4cyte.com.au
- Company type
- Private
- Founded year
- 2018
- Headcount range
- 11–50 employees
- Short description
- 4Cyte Pathology is an Australian independent specialist pathology laboratory founded in 2018 and headquartered in Ryde, NSW, providing diagnostic testing services to the Australian healthcare market via GP and specialist referrals.
- Ownership category
- akta.pro rank
4Cyte Pathology industry classification
Industry- Product category
- Diagnostic Pathology Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)
- akta.pro secondary industry
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where 4Cyte Pathology is headquartered
LocationHeadquarters
- HQ city
- Ryde
- HQ country
- Australia
- HQ region
- Oceania
Markets served
4Cyte Pathology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D
4Cyte Pathology product offering
Product offeringCore offering
4Cyte Pathology is an independent specialist medical laboratory that provides diagnostic pathology testing services to patients across Australia. The company receives patient specimens referred by general practitioners and medical specialists and processes them in its laboratories to deliver diagnostic results that inform clinical decision-making.
Differentiator
Problem solved
Functional benefit
Companies that use 4Cyte Pathology
Customer profileIdeal customer profiles1 record
4Cyte Pathology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
4Cyte Pathology competitors and assessment
Company assessmentDirect peers
- Australian Clinical Labs: ASX-listed pathology operator (ACL) running a national network of collection centres and laboratories across Australia. Closest direct comparable to 4Cyte in service mix, customer base (GPs/specialists/hospitals), and geographic market.
- Sonic Healthcare: ASX-listed global pathology and radiology operator and the dominant Australian pathology network (Sullivan Nicolaides, Douglass Hanly Moir, Melbourne Pathology, etc.). Direct competitor for GP-referred work, with substantially larger scale and IT infrastructure.
- Healius: ASX-listed operator of one of Australia's three major pathology networks (QML, Laverty, Dorevitch, Western Diagnostic Pathology). Direct competitor targeting the same GP-referred and specialist workflow as 4Cyte.
- Capital Pathology: ACT and surrounds pathology provider operating collection centres and a central lab; comparable in service mix and GP-referral model, useful benchmark for a regional Australian pathology operator.
- Clinipath Pathology: Western Australian pathology provider offering routine and specialist pathology to GPs and specialists. Comparable scope of services and customer base to 4Cyte, with similar regional-network economics.
Emerging players
- Histopath Diagnostic Specialists: Independent specialist histopathology laboratory in Australia focused on skin and tissue diagnostics. Comparable independent-specialist positioning to 4Cyte and useful proxy for the niche-lab economics 4Cyte targets.
- SDx (Specialist Diagnostic Services): Australian specialist pathology provider focused on dermatopathology and women's health screening. Comparable independent-specialist positioning, niche sub-segment focus, and Australian geographic footprint to 4Cyte.
Broad incumbents
- Quest Diagnostics: US-listed global clinical laboratory and diagnostics giant. Comparable core business (anatomic and clinical pathology, esoteric testing) and useful for international benchmark on unit economics, even though not a direct Australian competitor.
- Laboratory Corporation of America (Labcorp): US-listed global clinical laboratory operator with extensive anatomic pathology and specialty testing menu. Comparable core lab-services offering and useful international benchmark for independents scaling specialty menus.
Regional players
- Virtus Health: ASX-listed Australian specialty diagnostics and fertility services operator. Not a pure pathology peer, but comparable as a specialist Australian diagnostics operator with adjacent service lines and similar regulatory/operating environment.
Market position
Customer concentration
4Cyte Pathology financial estimates
Financial estimateRevenue estimate
Valuation estimate
4Cyte Pathology leadership team
Management profileNumber of profiles
Profiles2 records
4Cyte Pathology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
4Cyte Pathology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 4Cyte Pathology
What does 4Cyte Pathology do?
4Cyte Pathology is an independent specialist medical laboratory that provides diagnostic pathology testing services to patients across Australia. The company receives patient specimens referred by general practitioners and medical specialists and processes them in its laboratories to deliver diagnostic results that inform clinical decision-making.
When was 4Cyte Pathology founded?
4Cyte Pathology was founded in 2018. It employs 11 to 50 people.
Where is 4Cyte Pathology based?
4Cyte Pathology is headquartered in Ryde, Australia, in the Oceania region.
Who are 4Cyte Pathology's main competitors?
Direct peers on record are Australian Clinical Labs, Sonic Healthcare, Healius, Capital Pathology and Clinipath Pathology. Emerging players are Histopath Diagnostic Specialists and SDx (Specialist Diagnostic Services). Broad incumbents are Quest Diagnostics and Laboratory Corporation of America (Labcorp). Virtus Health is listed as a regional player.
Does 4Cyte Pathology have an API?
No public API is recorded for 4Cyte Pathology.
What industry is 4Cyte Pathology in?
4Cyte Pathology's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 621511 and its SIC code is 8071.